Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? D Unal, C Eroglu, N Kurtul, A Oguz, A Tasdemir Asian Pacific Journal of Cancer Prevention 14 (9), 5237-5242, 2013 | 222 | 2013 |
Prealbumin is a more sensitive marker than albumin to assess the nutritional status in patients undergoing radiotherapy for head and neck cancer D Unal, O Orhan, C Eroglu, B Kaplan Contemporary Oncology/Współczesna Onkologia 17 (3), 276-280, 2013 | 75 | 2013 |
Albumin-globulin ratio for prediction of long-term mortality in lung adenocarcinoma patients AO Duran, M Inanc, H Karaca, I Dogan, V Berk, O Bozkurt, E Ozaslan, ... Asian Pacific Journal of Cancer Prevention 15 (15), 6449-6453, 2014 | 71 | 2014 |
Meme Kanseri Risk Değerlendirmesi: 5000 Olgu. C Eroglu, MA Eryilmaz, S Civcik, Z Gurbuz UHOD: International Journal of Hematology & Oncology/Uluslararasi Hematoloji …, 2010 | 56 | 2010 |
Protective effects of caffeic acid phenethyl ester on radiation induced lung injury in rats OG Yildiz, S Soyuer, R Saraymen, C Eroglu Clinical and Investigative Medicine 31 (5), E242-E247, 2008 | 54 | 2008 |
Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing … C Eroglu, C Pala, L Kaynar, K Yaray, MT Aksozen, M Bankir, G Zararsız, ... Leukemia & lymphoma 54 (11), 2474-2479, 2013 | 46 | 2013 |
Serviks kanseri için riski olan kadınlarda HPV tiplendirmesi ve HPV sıklığının risk faktörleri ve servikal smearle ilişkisi C Eroğlu, R Keşli, MA Eryılmaz, Y Ünlü, O Gönenç, Ç Çelik Nobel Med 7 (3), 72-77, 2011 | 28 | 2011 |
Aminoguanidine ameliorates radiation-induced oxidative lung damage in rats C Eroglu, OG Yildiz, R Saraymen, S Soyuer, E Kilic, S Ozcan Clinical and Investigative Medicine 31 (4), E182-E188, 2008 | 25 | 2008 |
Preliminary results of a phase II study of weekly paclitaxel (PTX) and carboplatin (CBDCA) administered concurrently with thoracic radiation therapy (TRT) followed by … B Kaplan, M Altýnbas, C Eroglu, E Karahacioglu, O Er, M Ozkan, M Bilgin, ... American journal of clinical oncology 27 (6), 603-610, 2004 | 23 | 2004 |
Flow cytometry method as a diagnostic tool for pleural fluid involvement in a patient with multiple myeloma M Keklik, S Sivgin, C Pala, C Eroglu, G Akyol, L Kaynar, MY Koker, ... Mediterranean Journal of Hematology and Infectious Diseases 4 (1), 2012 | 22 | 2012 |
ABO blood groups are not associated with treatment response and prognosis in patients with local advanced non-small cell lung cancer D Unal, C EROĞLU, N Kurtul, A Oguz, A Tasdemir, B Kaplan Asian Pacific Journal of Cancer Prevention 14 (6), 2013 | 21 | 2013 |
Foramen transversarium bipartita A Aydınlıoğlu, A Kavaklı, H Yeşilyurt, S Erdem, C Eroğlu Van Tıp Dergisi 8 (4), 110-112, 2001 | 20 | 2001 |
Prognostic value of SPARC expression in unresectable NSCLC treated with concurrent chemoradiotherapy N Kurtul, C EROĞLU, D Unal, E Tasdemir, O Orhan, G ZARARSIZ, ... Asian Pacific Journal of Cancer Prevention 15 (20), 2014 | 18 | 2014 |
Is human kallikrein-11 in gastric cancer treated with surgery and adjuvant chemoradiotherapy associated with survival? D Unal, A Tasdemir, A Oguz, C Eroglu, YB Cihan, EE Turak, H Karaman, ... Pathology-Research and Practice 209 (12), 779-783, 2013 | 17 | 2013 |
Effect of serum selenium levels on radiotherapy-related toxicity in patients undergoing radiotherapy for head and neck cancer C Eroglu, D Unal, A Cetin, O Orhan, S Sivgin, A Oztürk Anticancer research 32 (8), 3587-3590, 2012 | 16 | 2012 |
Breast cancer risk assessment: 5000 cases C Eroglu, MA Eryilmaz, S Civcik, Z Gurbuz International Journal of Hematology and Oncology 33 (4), 027-033, 2010 | 16 | 2010 |
SPARC: As a prognostic biomarker in rectal cancer patients treated with chemo-radiotherapy N Kurtul, EA Taşdemir, D Ünal, M İzmirli, C Eroglu Cancer Biomarkers 18 (4), 459-466, 2017 | 14 | 2017 |
Is human kallikrein 11 in non-small cell lung cancer treated chemoradiotherapy associated with survival? D Unal, C Eroglu, A Tasdemir, H Karaman, N Kurtul, A Oguz, SS Goksu, ... Cancer research and treatment: official journal of Korean Cancer Association …, 2016 | 14 | 2016 |
A comparison of cisplatin cumulative dose and cisplatin schedule in patients treated with concurrent chemo-radiotherapy in nasopharyngeal carcinoma M Gundog, H Basaran, O Bozkurt, C Eroglu Brazilian Journal of Otorhinolaryngology 86 (6), 676-686, 2020 | 13 | 2020 |
Concomitant chemoradiotherapy with docetaxel and cisplatin followed by consolidation chemotherapy in locally advanced unresectable non-small cell lung cancer C Eroglu, O Orhan, D Unal, GG Dogu, H Karaca, M Dikilitas, A Oztürk, ... Annals of Thoracic Medicine 8 (2), 109-115, 2013 | 13 | 2013 |